CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Marisol Salgado-Albarrán, Julian Späth, Rodrigo González-Barrios, Jan Baumbach, and Ernesto Soto-Reyes

Journal title: Systems Biology and Applications

Journal number: 8

Journal publisher: Nature Publishing Group

Published year: 2022

DOI identifier: 10.1038/s41540-022-00214-z

ISSN: 2056-7189